Prospective Observational Cohort Study to Describe the Use of Vectibix® in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type KRAS Metastatic Colorectal Cancer (20120100)

30/11/2012
26/11/2025
EU PAS number:
EUPAS3180
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Vectibix_20120100_Protocol_113012

English (569.55 KB - PDF) View document
Updated protocol

20120100 Protocol Amend 4 2015-04-09 English_2

First published: 22/02/2024
English (754.68 KB - PDF) View document
Study results
Study results

CICERO_ORSR_abstract_20170816 (002)

English (112.78 KB - PDF) View document
Study report
Other information